What Is Ozempic Used For? Indications, Side Effects, and Facts

FDA-approved use: type 2 diabetes (adjunct to diet and exercise) • Active ingredient: semaglutide • Drug class: GLP-1 receptor agonist • Common dosage: 0.25 mg weekly (start), titrated to 1.0 mg weekly • Primary benefit: improves glycemic control and reduces cardiovascular risk

What is Ozempic used for?

Ozempic (semaglutide) is a once-weekly GLP-1 receptor agonist. In the US, it is indicated along with diet and exercise to improve blood sugar in adults with type 2 diabetes mellitus, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes mellitus and known heart disease FDA Ozempic label.

Official FDA-approved indications

The FDA label specifies two indications: glycemic control in type 2 diabetes and cardiovascular risk reduction in high-risk patients. The drug is not approved for weight loss alone.

Reducing cardiovascular risk in type 2 diabetes

The FDA expanded Ozempic’s cardiovascular indication on January 16, 2020, based on results from the SUSTAIN 6 cardiovascular outcomes trial Novo Nordisk / PR Newswire release on FDA action. The pattern: this approval marked a shift in diabetes treatment toward agents that offer heart protection beyond glucose lowering.

How does Ozempic help to lose weight?

Weight loss is a secondary effect of GLP-1 receptor agonism. Semaglutide activates GLP-1 receptors, which increases insulin secretion, delays gastric emptying, and suppresses appetite. Studies show average weight loss of 4–6 kg in diabetes trials EMA Ozempic product information.

Mechanism: appetite suppression and delayed gastric emptying

The drug slows how quickly food leaves the stomach and sends signals to the brain that reduce hunger. This leads to lower caloric intake.

Clinical evidence of weight reduction in diabetes patients

EMA data reports nausea in 17–19.9% of patients, diarrhea in 12.2–13.3%, and vomiting in 6.4–8.4%, which contribute to weight reduction but are side effects, not the intended outcome EMA Ozempic product information. The catch: the weight loss seen in diabetes trials is modest compared to dedicated weight-loss drugs like Wegovy (2.4 mg semaglutide).

Can you take Ozempic without diabetes?

Legally, a doctor can prescribe Ozempic off-label for weight loss, but it is not FDA-approved for non-diabetic weight loss. American Diabetes Association guidelines only recommend GLP-1s for diabetes management. Non-diabetic use carries an unknown long-term safety profile.

Legal/regulatory status: off-label for weight loss

Prescribing Ozempic for weight loss in people without diabetes is off-label. No large-scale clinical trials have established safety or efficacy in this population.

Risks of non-diabetic use

Using Ozempic without diabetes means accepting side effects like nausea, vomiting, diarrhea, and rare serious events such as pancreatitis, gallbladder disease, and thyroid tumors without a corresponding approved benefit Cleveland Clinic.

Why would a doctor prescribe Ozempic?

Doctors prescribe Ozempic for adults with type 2 diabetes and established cardiovascular disease. It is also used when metformin is insufficient or contraindicated. The American Diabetes Association recommends GLP-1 receptor agonists with proven cardiovascular benefit in patients with type 2 diabetes and established or high risk of ASCVD FDA Ozempic label.

Type 2 diabetes management

Ozempic helps lower blood sugar by stimulating insulin secretion when glucose is high. It is a second-line treatment after metformin for many patients.

Cardiovascular risk reduction in high-risk patients

The FDA label states Ozempic reduces the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease FDA Ozempic label. The implication: doctors target this drug for patients who need both glucose control and heart protection.

What is the biggest side effect of Ozempic?

The most common adverse reactions reported in at least 5% of Ozempic-treated patients are nausea, vomiting, diarrhea, abdominal pain, and constipation Novo PI. The FDA label also highlights pancreatitis as a serious side effect warning Novo Nordisk / PR Newswire release on FDA action.

Common gastrointestinal side effects

Nausea and vomiting are the most frequently reported, affecting roughly one in five patients. These typically diminish over time.

Serious adverse events: pancreatitis, gallbladder disease

Serious risks include acute pancreatitis, gallbladder disease, kidney injury, and allergic reactions Cleveland Clinic. Additionally, EMA’s PRAC concluded on June 6, 2025, that NAION (an eye condition) should be added as a very rare side effect of semaglutide medicines, possibly affecting up to 1 in 10,000 users EMA news release.

Frequently Asked Questions

Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.

— FDA prescribing information for Ozempic

Some people lose weight while taking Ozempic, but it is not licensed for weight loss alone.

— Diabetes UK patient information

GLP-1 receptor agonists with proven cardiovascular benefit are recommended in patients with type 2 diabetes and established/high risk of ASCVD.

— American Diabetes Association Standards of Care 2023

The implication for readers: Ozempic is a tool for type 2 diabetes management with heart benefits, not a shortcut for weight loss. Its approved uses are clearly defined by regulatory agencies.